Navigation Links
R. Lindholm Named to Crux Biomedical Board
Date:3/14/2011

MENLO PARK, Calif., March 14, 2011 /PRNewswire/ -- Crux Biomedical, developer of an advanced implantable vena cava filter (IVCF) to prevent pulmonary embolisms, announced the appointment of Randy Lindholm to its Board of Directors. Mr. Lindholm is a widely respected advisor to the medical device field. He was previously Chairman and CEO of Vidamed,  a maker of minimally invasive medical devices to treat benign prostate hyperplasia until it was acquired by Medtronic in 2002.  Prior to Vidamed, Randy held senior positions at Nellcor Puritan Bennett and GE Medical Systems. " I am excited to join Crux Biomedical. They are well positioned to take advantage of the current interest in a better performing retrievable IVC filter," stated Mr. Lindholm. He currently serves as director of publically held Omnicell (MLCL), Barrx Medical, Tibion Bionic Technologies, Estech and Novasys Medical.

"We are very pleased to have Randy's operating experience at Crux," states Mel Schatz, CEO of Crux Biomedical. He continued, "Randy has assisted numerous firms in securing venture backed funding."  Crux Biomedical is currently enrolling patients in its pivotal IDE study in the United States and several sites internationally. It expects to complete the U.S. study in 2011 and launch internationally  later this year.

Crux Biomedical was founded in 2004 by Thomas Fogarty, M.D., to target the development of an advanced implantable inferior vena cava filter (IVCF) to prevent the occurrence of potentially fatal pulmonary embolisms. Although routinely used in the United States, currently cleared IVC filters are associated with a variety of complications. "We recognized current IVC filters did not meet the needs of clinicians and designed a filter that provided better retrievability," stated Tom Fogarty, M.D.

Each year in the United States approximately 600,000 patients develop a PE and an estimated 200,000 deaths occur. Pulmonary embolisms are recognized as the most frequent cause of death among hospitalized patients.

Crux Biomedical is located in Menlo Park, California and is funded by Alloy Ventures and Emergent Medical Partners.


'/>"/>
SOURCE Crux Biomedical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named Woman of the Year by Arthritis Foundation
2. Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader
3. Living Medical eTextbook iPhone App from Projects In Knowledge® Named to Top 20 List of Free Medical Apps
4. Dawn Phillips Named as Vice President, Business Development for Catastrophic & Home Health Services
5. Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomens Association
6. Dynatronics Named Contract Supplier to Amerinets 50,000 Members
7. R&J Public Relations Named Agency of Record for Aerocrine, Inc.
8. Stryker Corporation Named One of FORTUNE Magazines 100 Best Companies to Work For
9. Kevin Banion Named CEO of Progressive Medical, Inc.
10. Webmedx Named Best in KLAS and Ranked #1 Transcription Services Vendor for Second Year in a Row
11. Elektas MOSAIQ Oncology Information System Named Category Leader in 2010 Top 20 Best in KLAS Awards Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2018)... ... November 16, 2018 , ... Florida Hospital, Championship Level ... the Title Sponsor of the 18th Annual Florida Hospital Bolt Run, Saturday, November 17, ... with the first-ever finisher’s circle inside AMALIE Arena just a few feet away from ...
(Date:11/16/2018)... ... 2018 , ... Mytonomy, a leader in virtual digital health ... the usability of and satisfaction with Mytonomy’s video-based microlearning platform among people living ... the 18th Annual Diabetes Technology Society Meeting, showed that patients were highly satisfied ...
(Date:11/16/2018)... ... November 16, 2018 , ... ... is thrilled to announce the launch of its newly redesigned website. , ... the company's mission and products. The newly redesigned website will be regularly updated ...
Breaking Medicine Technology:
(Date:11/16/2018)... ... ... AP was selected in the Health Care 2 ($10-$30M) Category and will be ... Hyatt Regency Downtown Dallas along with other companies who have illustrated exceptional qualities during ... Annual Excellence in Construction National Level Competition through Associated Builders and Contractors, Inc (ABC). ...
(Date:11/16/2018)... , ... November 16, 2018 , ... Nutrex Research ... skin care product called Lipo-6 Defining Gel . Utilizing TopiSorbTM Technology, this gel ... Stubborn cellulite and fatty deposits have met their match. , Maximizing fat loss ...
(Date:11/16/2018)... NEW YORK (PRWEB) , ... November 16, 2018 ... ... academic medical center, announced today a historic agreement with Taikang Healthcare in China ... for Taikang’s Xianlin Drum Tower Hospital in Nanjing, the capital of Jiangsu Province ...
(Date:11/16/2018)... ... November 16, 2018 , ... The ... China Resources Microelectronics Limited (CR Micro) and China Resources Life Science Industry ... establishing two joint research centres for novel micro-electronic devices and precision medicine. ...
(Date:11/15/2018)... ... November 15, 2018 , ... ... investment from Winnebago Seed Fund and additional investors including Wind River Financial, a ... forge a strategic partnership with Wind River to provide a range of solutions ...
Breaking Medicine News(10 mins):